Stock listing

NASDAQ:RARX Ra Pharmaceuticals Inc Stock

Follow Ra Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RARX

$47.99 USD

Close on Apr 1, 2020 · No longer trades

Oct 26, 2016 to last close +269.2% · weekly closes, Oct 26, 2016 – Apr 1, 2020
Lowest – highest close
$5.16 – $48.01 USDSince Oct 26, 2016 · lowest Apr 2, 2018 · highest Mar 31, 2020

Delisted NASDAQ:RARX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RARX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ra Pharmaceuticals Inc on 6ix

Decks
4 decks · latest Jun 7, 2018

Decks

DeckKindSlidesDate
Investor Presentation (June 2018)Investor deck23 slidesJun 7, 2018
Corporate Update (December 2017)Corporate update29 slidesDec 8, 2017
Investor Presentation (April 2017)Investor deck34 slidesApr 4, 2017
Technical Presentation (December 2016)Technical6 slidesDec 2, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past)
Director · Oct 25, 2016 – Apr 2, 2020 · Past
Edward Mathers
Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Senti Biosciences Holdings, Inc. (Director · Since at least Jun 8, 2022); OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Inozyme Pharma Inc (Director · Jul 23, 2020 – Jun 18, 2024 · Past); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past)
Director · Jun 28, 2018 – Apr 2, 2020 · Past
Alexander Cumbo
Other companies: Stoke Therapeutics, Inc. (Director · Since at least Sep 23, 2026); Vor Biopharma Inc. (Chair of the Compensation Committee · Since at least Jul 16, 2025); Climb Bio, Inc. (Director · Since at least Mar 28, 2025); Solid Biosciences Inc. (President and CEO, Director · Since at least Dec 2, 2022); Verve Therapeutics Inc (Director · Since at least Jun 9, 2022); Sarepta Therapeutics, Inc. (EVP, Chief Commercial Officer · Mar 5, 2018 – Feb 28, 2020 · Past)
Director · Nov 14, 2018 – Apr 2, 2020 · Past
Jason Lettmann
Other companies: ALX Oncology Holdings Inc. (Chief Executive Officer · Since at least Jul 16, 2020)
Director · Oct 25, 2016 – Jun 20, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Ra Pharmaceuticals Inc.